RYBREVANT SC 1600 mg/10 ml sol inj 1600 mg 1 pce

7680698390015 Pharmacode 1154815 CH-69839 L01FX18 07.16.1.

Active substances:

No images available

Details

GTIN
7680698390015
Pharmacode
1154815
Product number
6983901
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
amivantamabum 1600 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80 6 mg, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 6.19 mg.

Articles (1)

Rybrevant SC 1600 mg/10 ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/06/2026
Professional SmPC
Français
04/06/2026
Professional SmPC
Italien
04/06/2026

Detailed composition

Substance Quantity Type Category
amivantamabum
1600.0 MG Substance Wirkstoff (Principe actif)
hyaluronidasum humanum ADNr
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
6.0 MG Substance HBESI
methioninum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
6.19 MG Substance HBESI

Reimbursement information

Public price
CHF 3864.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
69839
Drug name
Rybrevant SC, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FX18
Authorization status
Z
Dispensation category
A
First authorization
28/01/2026
Authorization expiration date
27/01/2031
IT number
07.16.1.
Domain
Human medicine
Field of application
Nicht-kleinzelliges Lungenkarzinom

Packaging details

Description (FR)
RYBREVANT SC 1600 mg/10 ml sol inj 1600 mg 1 pce
Description (DE)
RYBREVANT SC 1600 mg/10 ml Inj Lös 1600 mg 1 Stk
Market launch
20/02/2026
Narcotic (BTM)
No

Other packaging sizes

RYBREVANT SC 2240 mg/14 ml sol inj 2240 mg 1 pce
1 DUR
View
Buy us a coffee Explore the data